A detailed history of M. Kulyk & Associates, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, M. Kulyk & Associates, LLC holds 4,374 shares of JNJ stock, worth $720,922. This represents 0.15% of its overall portfolio holdings.

Number of Shares
4,374
Previous 4,527 3.38%
Holding current value
$720,922
Previous $716,000 10.75%
% of portfolio
0.15%
Previous 0.17%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$144.38 - $157.78 $22,090 - $24,140
-153 Reduced 3.38%
4,374 $639,000
Q1 2024

May 09, 2024

BUY
$155.22 - $162.74 $187,816 - $196,915
1,210 Added 36.48%
4,527 $716,000
Q4 2023

Feb 08, 2024

SELL
$145.6 - $158.88 $16,598 - $18,112
-114 Reduced 3.32%
3,317 $519,000
Q3 2023

Nov 07, 2023

SELL
$155.75 - $174.48 $17,132 - $19,192
-110 Reduced 3.11%
3,431 $534,000
Q2 2023

Aug 08, 2023

SELL
$154.35 - $166.11 $48,465 - $52,158
-314 Reduced 8.15%
3,541 $586,000
Q1 2023

May 08, 2023

SELL
$151.05 - $180.26 $22,657 - $27,039
-150 Reduced 3.75%
3,855 $597,000
Q4 2022

Feb 08, 2023

BUY
$160.2 - $179.79 $136,330 - $153,001
851 Added 26.98%
4,005 $707,000
Q3 2022

Nov 07, 2022

BUY
$161.33 - $179.52 $1,613 - $1,795
10 Added 0.32%
3,154 $515,000
Q2 2022

Aug 05, 2022

SELL
$168.19 - $186.01 $41,542 - $45,944
-247 Reduced 7.28%
3,144 $558,000
Q1 2022

May 11, 2022

BUY
$158.14 - $179.59 $30,046 - $34,122
190 Added 5.94%
3,391 $601,000
Q4 2021

Jan 20, 2022

SELL
$155.93 - $173.01 $13,409 - $14,878
-86 Reduced 2.62%
3,201 $548,000
Q3 2021

Oct 21, 2021

BUY
$161.5 - $179.47 $17,280 - $19,203
107 Added 3.36%
3,287 $531,000
Q2 2021

Jul 21, 2021

SELL
$159.48 - $171.07 $92,657 - $99,391
-581 Reduced 15.45%
3,180 $524,000
Q1 2021

Apr 29, 2021

BUY
$153.07 - $170.48 $93,831 - $104,504
613 Added 19.47%
3,761 $618,000
Q4 2020

Feb 02, 2021

BUY
$137.11 - $157.38 $431,622 - $495,432
3,148 New
3,148 $495,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track M. Kulyk & Associates, LLC Portfolio

Follow M. Kulyk & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M. Kulyk & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on M. Kulyk & Associates, LLC with notifications on news.